A5057245327- Diabetes, Cardiovascular Risks, and Lipoproteins
- HIV-related health complications and treatments
- Chronic Disease Management Strategies
- Global Public Health Policies and Epidemiology
- HIV/AIDS Research and Interventions
- Trypanosoma species research and implications
- Blood Pressure and Hypertension Studies
- Diabetes Management and Education
- Healthcare Systems and Reforms
- COVID-19 Clinical Research Studies
- HIV/AIDS Impact and Responses
- Health Systems, Economic Evaluations, Quality of Life
- HIV, Drug Use, Sexual Risk
- Global Health Care Issues
- COVID-19 and healthcare impacts
- Cardiovascular Health and Risk Factors
- Health disparities and outcomes
- Research on Leishmaniasis Studies
- Diversity and Career in Medicine
- Obesity, Physical Activity, Diet
- Global Maternal and Child Health
- Lipoproteins and Cardiovascular Health
- Diabetes and associated disorders
- HIV Research and Treatment
- Tuberculosis Research and Epidemiology
Brigham and Women's Hospital
2019-2025
Massachusetts General Hospital
2018-2025
Harvard University
2016-2025
Agincourt Health and Socio-Demographic Surveillance System
2024
Washington University in St. Louis
2023-2024
University of the Witwatersrand
2022-2024
University of Göttingen
2024
Zero to Three
2024
Universidade Federal de Minas Gerais
2024
Diabetes Australia
2023
OBJECTIVE Despite the importance of diabetes for global health, future economic consequences disease remain opaque. We forecast full costs in adults through year 2030 and predict if targets under Sustainable Development Goals (SDG) World Health Organization Global Action Plan Prevention Control Noncommunicable Diseases 2013–2020 are met. RESEARCH DESIGN AND METHODS modeled absolute gross domestic product (GDP)-relative burden individuals aged 20–79 years using epidemiological demographic...
Understanding how diabetes and hypertension prevalence varies within a country as large India is essential for targeting of prevention, screening, treatment services. However, to our knowledge there has been no prior nationally representative study these conditions guide the design effective policies.To determine in India, its variation by state, rural vs urban location, individual-level sociodemographic characteristics.This was cross-sectional, representative, population-based carried out...
Background The prevalence of diabetes is increasing rapidly in low- and middle-income countries (LMICs), urgently requiring detailed evidence to guide the response health systems this epidemic. In an effort understand at what step care continuum individuals are lost care, how varies between population groups, study examined system performance for among adults 28 LMICs using a cascade approach. Methods findings We pooled individual participant data from nationally representative surveys done...
Background In recent years, there has been growing awareness of the significant burden Chagas disease in United States (US). However, epidemiological data on both prevalence and access to care for this are limited. The objective study is provide an updated national estimate prevalence, first state-level estimates cases T. cruzi infection US analyze these context confirmed blood supply. Methods study, we calculated state disease. number residents originally from endemic countries were...
Background Evidence on where in the hypertension care process individuals are lost to care, and how this varies among states population groups a country as large India, is essential for design of targeted interventions monitor progress. Yet, our knowledge, there has not yet been nationally representative analysis proportion adults who reach each step India. This study aimed determine (i) with have screened, aware their diagnosis, take antihypertensive treatment, achieved control (ii)...
Approximately 80% of the 463 million adults worldwide with diabetes live in low- and middle-income countries (LMICs). A major obstacle to designing evidence-based policies improve outcomes LMICs is limited nationally representative data on current patterns treatment coverage. The objectives this study are (1) estimate proportion who receive coverage recommended pharmacological non-pharmacological (2) describe country-level individual-level characteristics that associated treatment.We...
OBJECTIVEDiabetes is a rapidly growing health problem in low- and middle-income countries (LMICs), but empirical data on its prevalence relationship to socioeconomic status are scarce. We estimated diabetes the subset with undiagnosed 29 LMICs evaluated of education, household wealth, BMI risk.
<h3>Importance</h3> The World Health Organization is developing a global strategy to eliminate cervical cancer, with goals for screening prevalence among women aged 30 through 49 years. However, evidence on levels of cancer in low- and middle-income countries (LMICs) sparse. <h3>Objective</h3> To determine lifetime LMICs its variation across within world regions countries. <h3>Design, Setting, Participants</h3> Analysis cross-sectional nationally representative household surveys carried out...
Diabetes and obesity are highly prevalent among hospitalized patients with coronavirus disease 2019 (COVID-19), but little is known about their contributions to early COVID-19 outcomes. We tested the hypothesis that diabetes a risk factor for poor outcomes, after adjustment obesity, cohort of COVID-19.
There are 300,000 estimated cases of Chagas disease in the United States but limited data on access to care. This study analyzed trends care for and assessed national state barriers access. Data blood donors drug releases were obtained from AABB (formerly American Association Blood Banks) U.S. Centers Disease Control Prevention (CDC), respectively. Semi-structured in-depth interviews conducted with 30 key informants at level five states where treatment had been released. Interview responses...
A consequence of the widespread uptake anti-retroviral therapy (ART) is that older South African population will experience an increase in life expectancy, increasing their risk for cardiometabolic diseases (CMD), and its factors. The long-term interactions between HIV infection, treatment, CMD remain to be elucidated population. HAALSI cohort was established investigate impact these on morbidity mortality among middle-aged adults.We recruited randomly selected adults aged 40 or residing...
The prevalence of diabetes and hypertension has increased in HIV-positive populations, but there is limited understanding the role that antiretroviral therapy (ART) programs play delivery services for these conditions. aim this study to assess relationship between ART use utilization health care hypertension.Health Aging Africa: A Longitudinal Study an INDEPTH Community South Africa a cohort 5059 adults. baseline collects biomarker-based data on HIV, ART, diabetes, self-reported utilization....
Background Cardiovascular disease (CVD) is the leading cause of mortality in India. Yet, evidence on CVD risk India's population limited. To inform health system planning and effective targeting interventions, this study aimed to determine how risk—and factors that risk—varies among states India, by rural–urban location, individual-level sociodemographic characteristics. Methods findings We used 2 large household surveys carried out between 2012 2014, which included a sample 797,540 adults...
The rapid ageing of populations around the world is accompanied by increasing prevalence multimorbidity. This study one first to present multimorbidity that includes HIV in complex epidemiological setting South Africa, thus filling a gap literature dominated studies high-income or low-HIV settings.Out full sample 5059 people aged 40+, we analysed cross-sectional data on 10 conditions from 3889 enrolled Health and Ageing Africa: A longitudinal an INDEPTH Community Africa (HAALSI) Programme....
Chagas disease affects an estimated 326 000-347 000 people in the United States and is severely underdiagnosed. Lack of awareness clarity regarding screening diagnosis a key barrier. This article provides straightforward recommendations, with goal simplifying identification testing at risk for US healthcare providers.A multidisciplinary working group clinicians researchers expertise agreed on 6 main questions, developed recommendations based Grading Recommendations Assessment, Development...
In the prevention of cardiovascular disease, a WHO target is that at least 50% eligible people use statins. Robust evidence needed to monitor progress towards this in low-income and middle-income countries (LMICs), where most disease deaths occur. The objectives study were benchmark statin LMICs investigate country-level individual-level characteristics associated with use.We did cross-sectional analysis pooled, data from nationally representative health surveys done 41 between 2013 2019....
To determine the prevalence and frequency of using any tobacco product each a detailed set products, how use vary across countries, world regions, World Bank country income groups, socioeconomic demographic gradients within countries.